Home
>
US Stocks
>
Antares Pharma Inc
Antares Pharma Inc
ATRS

Antares Pharma Inc

$3.469.9%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
3.48
Today Low/High
3.44 / 3.49
52 Week Low/High
$2.57 / $5.07
P/E ratio
9.97
Market Cap
$644.18M

Company Details

Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), Covis Pharma (Covis), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma's FDA-approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. The Company also markets NOCDURNA® (desmopressin acetate) in the U.S., which was licensed from Ferring Pharmaceuticals.
Organisation
Antares Pharma Inc
Headquaters
Ewing, New Jersey, US
Employees
185
Industry
Health Technology
CEO
Robert Apple

Discover more

Frequently Asked Questions

What is Antares Pharma Inc share price today

Can Indians buy Antares Pharma Inc shares?

How can I buy Antares Pharma Inc shares from India?

Can Fractional shares of Antares Pharma Inc be purchased?

What are the documents required to start investing in Antares Pharma Inc stocks?

We are a SEBI registered investement advisor